Periodicals Home | Search | User Pref |
Help |
Archives Home | Current Issue |
All Issues |
Order | About this Journal |
<< Issue |
>> Issue |
K A Stolp-Smith [MEDLINE LOOKUP] |
|
Abstract | TOP |
Patients with spinal cord injury (SCI) may develop depression. This may be
related to adjustment to living with an SCI in addition to dealing with
complications of the injury, such as spasticity. Pharmacologic treatment of
depression can be difficult because of neurochemical and receptor changes that
are associated with SCI. Newer antidepressant agents are purported to have
selective activity by alteration of serotonergic neurotransmission. A case
report is presented that illustrates exacerbation of spasticity by this family
of antidepressant medications. Mechanisms possibly explaining this exacerbation
of spasticity are the effects of serotonin on motor neuron and reflex activity,
denervation supersensitivity, and the serotonin syndrome. Understanding the
relationship between serotonergic systems and spasticity can be important in
treating depression in patients with spasticity.
(Arch Phys Med Rehabil 1999
Mar;80(3):339-42)
Publishing and Reprint Information | TOP |